Table 1.
Reports of FDG uptake in hepatic AMLs to the present date
| Author | Age | Gender | Tumor size (cm) | SUVmax |
|---|---|---|---|---|
| Takanami [8] |
74 |
Female |
20 |
Low |
| 62 |
Female |
15 |
4.0 |
|
| Awane [15] |
48 |
Female |
6 |
Low |
| Kubo [16] |
70 |
Female |
3.2 |
1.9 |
| Kinugasa [17] |
42 |
Female |
1.4 |
3.9 |
| Sakaguchi [18] |
80 |
Female |
4.3 |
3.3 |
| Kawaoka [19] |
41 |
Female |
3.9 |
1.9 |
| Lhommel R [20] |
64 |
- |
7 |
Low |
| Lee JH [6] | 47 | Female | 4 | Low |
FDG, 18 F-fluorodeoxyglucose; AML, angiomyolipoma; SUVmax, maximum standard uptake value.